We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.20 | 2.00 | 2.40 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMODX
RNS Number : 2762L
Omega Diagnostics Group PLC
17 July 2017
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014
17 July 2017
Omega Diagnostics Group plc
Result of Open Offer
On 30 June 2017, Omega announced details of a Placing, Subscription and Open Offer to raise gross proceeds of approximately GBP3.6 million through the issue of up to 20,007,003 New Ordinary Shares at a price of 18 pence per share, with 13,116,881 shares subject to the Placing, 1,166,666 shares subject to the Subscription and up to a further 5,723,456 shares to be issued through the Open Offer.
The Open Offer closed for acceptances at 11.00 a.m. on 17 July 2017. Omega is pleased to announce that it has received valid applications under the Open Offer, including those received under the Excess Application Facility, in respect of 3,854,844 Open Offer Shares from Qualifying Shareholders. This represents approximately 67.4 per cent. of the Open Offer Shares. Qualifying Shareholders who have validly applied for Open Offer Shares and Excess Shares will receive their application in full.
The Placing, Subscription and Open Offer remain conditional, inter alia, upon the Resolutions being passed at the General Meeting to be held at 10.00 a.m. on 18 July 2017 and Admission. Omega expects to announce the results of the General Meeting as soon as practicable on 18 July 2017 after the meeting concludes. It is expected that Admission will become effective on 19 July 2017.
Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 30 June 2017.
Contacts:
Omega Diagnostics Group PLC Tel: 01259 763 030 Andrew Shepherd, Chief Executive www.omegadiagnostics.com Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director finnCap Ltd Tel: 020 7220 0500 Geoff Nash/James Thompson (Corporate Finance) Mia Gardner (Corporate Broking) Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROIRRMJTMBBBBAR
(END) Dow Jones Newswires
July 17, 2017 09:17 ET (13:17 GMT)
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
